Resultados de la búsqueda 771-780 of 3655 for Rabies

  1. Oncología (médica) - Ensayos clínicos

    The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...

  2. Oncología (médica) - Ensayos clínicos

    The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma, (RR ...

  3. Oncología (médica) - Ensayos clínicos

    The primary purpose of this study is to examine the effects of abemaciclib on the CD8/FOXP3 ratio in chemotherapy-resistant triple negative breast cancer (TNBC) ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells, by ...

  5. Neurocirugía - Ensayos clínicos

    This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing ...

  6. Mayo Clinic

    Share · Tweet. Nov. 20, 2018 . VID-20428726. Inicio; Gene Guide Ferber. Tu donación es muy poderosa... ¿quieres hacerla hoy mismo?

  7. Oncología (médica) - Ensayos clínicos

    This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has ...

  8. Brightcove-Development-Whole-exome sequencing changes Dustins life

    Brightcove-Development-Whole-exome sequencing changes Dustins life · [MÚSICA] · TÚ ERES… La campaña por Mayo Clinic · Linda Bennett: Dustin siempre fue un espíritu ...

  9. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different ...

  10. Hematología - Ensayos clínicos

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...